Gastrict Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer (NCT05223088) | Fujian Cancer Hospital | 2021-10-31 |
Track Gastrict Cancer automatically
Every clearance here is in the API, with alerts when new ones post.